P53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma

International Journal of Oncology

Volumn 14, Issue 1, 1999, Pages 175-179

  Iacopetta, Barry ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Endometrial cancer; P53; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CHEMISTRY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032614389     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Platz CE and Benda JA: Female genital tract cancer. Cancer 75: 270-294, 1995.
2. Di Saia PJ and Creasman WT: Clinical Gynecologic Oncology. Mosby-Year Book, Inc., St. Louis, 1993.
3. Konski A, Domenico D, Tyrkus M, Irving D, Neisler J, Phibbs G, Zeidncr S and Eggleston W: Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 35: 935-940, 1996.